在感染疟疾的红细胞上显示的RIFIN与KIR2DL1和KIR2DS1结合
Akihito Sakoguchi1, Samuel G Chamberlain2,3, Alexander M Mørch4
1Department of Protozoology, Research Institute for Microbial Diseases, The University of Osaka, Suita, Japan.
Nature
|June 11, 2025
概括
疟疾寄生虫使用RIFIN蛋白来逃避自然杀手细胞的检测. 这项研究显示,RIFIN可以通过结合激活免疫受体来激活NK细胞,从而提供一种新的抗疟疾策略.
科学领域:
- 免疫学
- 寄生虫学
- 分子生物学
背景情况:
- 自然杀手 (NK) 细胞对于宿主防御至关重要,它们利用激活和抑制免疫受体来区分自我与非自我.
- 杀手免疫球蛋白类受体 (KIRs) 是关键的免疫受体,通常存在于具有相似联结域的抑制和激活对.
- 通过与抑制性KIR结合,可以抑制NK细胞的活性,从而促进寄生虫的逃避.
研究的目的:
- 为了识别人类激活免疫受体的病原体衍生的配体.
- 研究RIFIN蛋白与抑制和激活KIR的相互作用.
- 探索针对疟疾控制这些相互作用的潜力.
主要方法:
- 生物化学测试以确定RIFIN-KIR的结合亲缘关系.
- 结构生物学阐明了RIFIN-KIR结合机制.
- 在现场隔离的疟疾菌株中分析RIFIN.
主要成果:
- 鉴定出与抑制性KIR2DL1强烈结合的RIFIN,抑制NK细胞激活.
- 证明这些RIFIN也与激活的KIR2DS1结合,激活NK细胞.
- 证实了这些RIFIN在Plasmodium falciparum的各种地理隔离物中存在.
结论:
- 病原体衍生的RIFIN可以通过抑制和激活KIR调节NK细胞活性.
- 这种双重相互作用机制突显了疟疾寄生虫的新型免疫逃避策略.
- 针对RIFIN-KIR相互作用,特别是激活KIR,为疟疾提供了潜在的治疗途径.
更多相关视频
10:22Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
Published on: December 4, 2015
8.9K
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
1.3K
相关概念视频
01:03Rous Sarcoma Virus (RSV) and Cancer
5.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.2K
01:19Rh Blood Group
4.4K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
4.4K